Switch to:
GuruFocus articles
Headlines from internet
Nov-22-17$83.91 (-1.40%)
08:44AMDaily Pharma Scoop Teva Valuation Delmar Lead Candidate Galapagos Commences Trial Seekingalpha
06:35AMBiotech Stock Roundup: RARE drug Gets FDA Nod, Acorda, Cytokinetics Hit by Pipeline Setbacks Zacks
Nov-21-17$85.1 (+1.87%)
09:25AMTESARO (TSRO) Ovarian Cancer Drug Zejula Gets Approval in EU Zacks
08:33AMDaily Pharma Scoop Roche Rallies Alnylam Granted Btd Celsion Soars Seekingalpha
Nov-15-17$86.32 (-0.47%)
09:31PMIs Opko Health Inc. a Buy? Fool
10:36AMMorning Movers: Target's Holiday Blues; Snap's Sapped Barron's
Nov-13-17$90.45 (-0.7%)
03:32PMDaily Pharma Scoop Regenerons Appeal Good News Amgen Bristol Myers Sprycel Seekingalpha
01:07AMTesaro Multiple Drivers Ahead Pulling Trigger Seekingalpha
Nov-09-17$91.01 (-7.55%)
03:26AMDaily Pharma Scoop Portola Upside Novartis Reports Positive Cosentyx Data Keryx Tumbles Seekingalpha
Nov-02-17$110.87 (-2.7%)
10:49AMClovis (CLVS) Q3 Loss Wider Than Expected, Revenues Miss Zacks
Oct-26-17$113.09 (+2.78%)
08:27AMSierra Oncology Significant Potential Upside 2018 Seekingalpha
Oct-23-17$113.64 (-2.37%)
12:35PMBiotech Forum Daily Digest Behind Uniqures Massive Rally Seekingalpha
Oct-19-17$115.51 (+1.68%)
08:30AMAstraZeneca's sNDA for Two Cancer Drugs Gets Priority Review Zacks
Oct-18-17$113.6 (-4.16%)
07:35AMAstra and Merck win speedy review for Lynparza in breast cancer cnbc
Oct-11-17$117.91 (-0.26%)
01:33PMAnaptysbio Atopic Dermatitis Data Impresses Buy Secondary Seekingalpha
08:00AM3 Things Biotech Learn Today September 30 2017 Seekingalpha
Sep-28-17$123.71 (+3.01%)
01:38PMClovis Attractive M Candidate Seekingalpha
Sep-19-17$118.74 (+0.25%)
11:24AMTesaro Attractive Valuation Ahead Key Regulatory Decisions Seekingalpha
Sep-18-17$118.44 (+1.09%)
11:30AMDaily Pharma Scoop Acadias Growth Potential Lexicons Diabetes Troubles Neos Post Approval Seekingalpha
Aug-24-17$125.85 (+4.53%)
11:31AMZai Lab Files To Raise $115 Million In US IPO Seekingalpha
Aug-22-17$120.62 (+1.48%)
11:10AMTesaro: Buy The Dip? Seekingalpha
09:00AM3 Things In Biotech You Should Learn Today: August 19, 2017 Seekingalpha
Aug-18-17$113.86 (+4.41%)
01:59PMSurprisingly Broad Lynparza Approval Levels The Playing Field Seekingalpha
12:36PMBiotech Forum Daily Digest: What's Next For Adamas Pharmaceuticals? Seekingalpha
08:00AMAstraZeneca, Time To Expand The Operation Seekingalpha
Aug-11-17$111.85 (+0.87%)
11:40PMTesaro 2017 Q2 - Results - Earnings Call Slides Seekingalpha
03:34PMTesaro: Strong Zejula Launch Bodes Well But Concerns Remain Seekingalpha
01:17PMClovis Positions Itself As A Long-Term Investment Opportunity With Several Catalysts Seekingalpha
Aug-04-17$128.59 (+3.24%)
10:19AMClovis Oncology: Revisiting After ARIEL3 Success Seekingalpha
Aug-02-17$124.41 (+0.73%)
01:58PMTesaro (TSRO) Presents At 2017 Biotech Corporate Access Day - Slideshow Seekingalpha
Aug-01-17$123.51 (-3.25%)
07:17PM3 Things In Biotech You Should Learn Today: August 2, 2017 Seekingalpha
Jul-21-17$131.97 (+2.29%)
12:03PMTesaro's Stock Dip Is Nothing To Be Afraid Of Seekingalpha
Jul-19-17$124.02 (+4.38%)
02:09PMFDA's Flashing Green Light Boosts Novel Drug Approvals Seekingalpha
Jul-12-17$138.35 (+4.47%)
12:09PMTesaro Shows Good Potential With Major Approvals This Year Seekingalpha
Jun-30-17$139.86 (-0.8%)
07:45AMOPKO Health Poised For Growth Seekingalpha
Jun-26-17$146.71 (-0.01%)
01:16PMIs Clovis Oncology A Takeover Candidate? Seekingalpha
Jun-20-17$137.97 (-3.49%)
12:56PM3 Things In Biotech You Should Learn Today: June 20, 2017 Seekingalpha
May-15-17$145.55 (-0.03%)
05:23PMGilead: Dead Money, Time For Investors To Move On Seekingalpha
May-04-17$143.59 (+1.97%)
01:16PMBest Biotech Stocks For Capital Gains In The Next 3 Months Seekingalpha
Apr-27-17$146.61 (+3.24%)
06:00AM3 Things In Biotech You Should Learn Today: April 27, 2017 Seekingalpha
Apr-21-17$136.01 (-2.16%)
03:33PMSnippet Roundup: Tesaro's Parp Pricing Stumble And Asco Sneak Peek Seekingalpha
09:20AMAbbvie's Parp Runs Out Of Puff Seekingalpha
07:00PMOphthotech Soars After Third-Quarter Results -- Biotech Movers theStreet
07:00PMOphthotech Soars After Third-Quarter Results -- Biotech Movers theStreet
07:00PMDBV Rises On Phase 3 Results for Peanut Allergy Treatment -- Biotech Movers theStreet
07:00PMDBV Rises On Phase 3 Results for Peanut Allergy Treatment -- Biotech Movers theStreet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat